SCARTOZZI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.854
AS - Asia 1.782
EU - Europa 1.336
SA - Sud America 284
Continente sconosciuto - Info sul continente non disponibili 99
AF - Africa 41
OC - Oceania 7
Totale 8.403
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.780
SG - Singapore 634
GB - Regno Unito 356
CN - Cina 300
VN - Vietnam 232
HK - Hong Kong 220
BR - Brasile 216
IT - Italia 204
FI - Finlandia 185
DE - Germania 166
BD - Bangladesh 139
SE - Svezia 139
FR - Francia 74
RU - Federazione Russa 73
TR - Turchia 67
ID - Indonesia 39
CA - Canada 32
BG - Bulgaria 31
IN - India 30
JP - Giappone 25
AR - Argentina 24
UA - Ucraina 19
IQ - Iraq 18
NL - Olanda 17
IE - Irlanda 14
VE - Venezuela 14
MX - Messico 11
PK - Pakistan 10
ZA - Sudafrica 10
EG - Egitto 9
AT - Austria 8
JM - Giamaica 8
KR - Corea 8
BE - Belgio 7
CO - Colombia 7
SA - Arabia Saudita 7
MY - Malesia 6
CH - Svizzera 5
CL - Cile 5
EC - Ecuador 5
JO - Giordania 5
MA - Marocco 5
PE - Perù 5
PH - Filippine 5
RO - Romania 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
BZ - Belize 4
CR - Costa Rica 4
GT - Guatemala 4
IL - Israele 4
LT - Lituania 4
LU - Lussemburgo 4
NO - Norvegia 4
NP - Nepal 4
OM - Oman 4
PY - Paraguay 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
KE - Kenya 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ES - Italia 2
HN - Honduras 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
IR - Iran 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
ML - Mali 1
MQ - Martinica 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
PA - Panama 1
PG - Papua Nuova Guinea 1
Totale 8.299
Salva come PNG Salva come JPEG
Città #
Fairfield 712
Ashburn 539
Santa Clara 421
Singapore 407
Seattle 304
Woodbridge 292
Chandler 251
Houston 249
Wilmington 219
Cambridge 218
Hong Kong 216
Southend 210
Helsinki 174
San Jose 161
Dearborn 117
Council Bluffs 116
Nyköping 106
London 98
Ann Arbor 74
New York 67
Beijing 61
Izmir 58
Ho Chi Minh City 55
Hanoi 50
San Diego 47
Dong Ket 44
The Dalles 40
Lauterbourg 38
Los Angeles 37
Jakarta 34
Munich 32
Milan 31
Princeton 31
Sofia 31
Boardman 30
Bremen 30
Chicago 30
Eugene 30
Phoenix 30
Shanghai 26
Orem 25
São Paulo 24
Tokyo 22
Modena 20
Buffalo 18
Redondo Beach 15
Dallas 14
Dublin 12
Falkenstein 10
Jacksonville 10
Frankfurt am Main 9
Turku 9
Atlanta 8
Cairo 8
Columbus 8
Hefei 8
Montreal 8
Portsmouth 8
Salt Lake City 8
Chennai 7
Da Nang 7
Denver 7
Haiphong 7
Kunming 7
Miano 7
Moscow 7
Norwalk 7
Seoul 7
Toronto 7
Baghdad 6
Curitiba 6
Guangzhou 6
Hanover 6
Naples 6
Rio de Janeiro 6
Salvador 6
Turin 6
Amsterdam 5
Brooklyn 5
Brussels 5
Charlotte 5
Criciúma 5
Jieyang 5
Mumbai 5
Vancouver 5
Amman 4
Baku 4
Belize City 4
Dhaka 4
Düsseldorf 4
Edinburgh 4
Hounslow 4
Jinan 4
Johannesburg 4
Lahore 4
Lima 4
Nanjing 4
North Bergen 4
Nuremberg 4
Redwood City 4
Totale 6.178
Salva come PNG Salva come JPEG
Nome #
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 361
Immunotherapy for colorectal cancer: where are we heading? 339
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients 321
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) 317
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 317
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma 313
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma 303
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial 293
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale 289
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib 284
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 284
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 279
Immunotherapeutic approaches for hepatocellular carcinoma 278
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 274
The Italian Rare Pancreatic Exocrine Cancer Initiative 270
Efficacy of sorafenib in BRAF-mutated nonsmall- cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report 267
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib 258
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials 255
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 253
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC) 253
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 249
Multicentric prospective study of validation of angiogenesis polymorphisms in HCC patients treated with sorafenib. INNOVATE study 248
The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer 248
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study 243
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma 243
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 237
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 231
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 224
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 220
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers? 186
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 142
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 124
Totale 8.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.079
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022548 0 22 23 36 15 45 13 49 62 76 129 78
2022/2023727 87 80 40 59 105 80 16 75 86 9 46 44
2023/2024288 9 16 10 45 65 2 33 40 3 7 8 50
2024/20251.399 39 24 5 116 286 229 141 84 190 45 75 165
2025/20262.254 125 47 97 179 366 159 310 83 227 212 246 203
2026/2027209 76 133 0 0 0 0 0 0 0 0 0 0
Totale 8.403